SFX by Ex Libris Inc.

Title:	Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study
Source:	Human Genetics [0340-6717] van Essen, Anthonie yr:1992

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Full text available via SpringerLink Historical Archives Biomedical and Life Sciences

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Makri, S. "Germinal mosaicism for LMNA mimics autosomal recessive congenital muscular dystrophy." Neuromuscular disorders 19.1 (2009): 26-28.
description	2.	Keira, Y. "Characterization of lobulated fibers in limb girdle muscular dystrophy type 2A by gene expression profiling." Neuroscience research 57.4 (2007): 513-21.
description	3.	Sorimachi, K. "Muscle-specific calpain-3 is phosphorylated in its unique insertion region for enrichment in a myofibril fraction." Genes to cells 19.11 (2014): 830-841.
description	4.	Daniele, N. "A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay." Neuromuscular disorders 17.2 (2007): 148-156.
description	5.	Fanin, M. "The frequency of limb girdle muscular dystrophy 2A in northeastern Italy." Neuromuscular disorders 15.3 (2005): 218-224.
description	6.	Inoue, M. "Expression of myoferlin in skeletal muscles of patients with dysferlinopathy." The Tohoku journal of experimental medicine 209.2 (2006): 109-116.
description	7.	Houlden, J. "Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2." Neurology 71.21 (2008): 1660-8.
description	8.	Moore, Christopher J. "Genes required for functional glycosylation of dystroglycan are conserved in zebrafish ☆ [☆] Sequence data from this article have been deposited with the GenBank Data Library under Accession Nos. DQ826745 (Fukutin), DQ826746 ..." Genomics 92.3 (2008): 159-.
description	9.	Pikó, H. "Dystrophin gene analysis in Hungarian Duchenne/Becker muscular dystrophy families - detection of carrier status in symptomatic and asymptomatic female relatives." Neuromuscular Disorders 19.2 (2009): 108-112.
description	10.	Durbeej, M. "Disruption of the Î²-Sarcoglycan Gene Reveals Pathogenetic Complexity of Limb-Girdle Muscular Dystrophy Type 2E." Molecular cell 5.1 (2000): 141-151.
description	11.	Jette, N. "A Systematic Review and Meta-analysis on the Epidemiology of Duchenne and Becker muscular dystrophy." Neuromuscular disorders In press.In press (2014): 482-91.
description	12.	Strehle, E. "Dysferlinopathy: from gene to protein." Journal of clinical neuromuscular disease (2008): 83-84.
description	13.	Wenzel, K. "Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding." Human mutation 27.6 (2006): 599-600.
description	14.	Tada, K. "Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy." Journal of neurology 238.7 (1991): 375-378.
description	15.	Yum, Sabrina W. "A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy." Annals of neurology (2009): 759-770.
description	16.	Nadkarni, J. "Becker muscular dystrophy in Indian patients: Analysis of dystrophin gene deletion patterns." Neurology India 56.3 (2008): 374-378.
description	17.	Iwata, Y. "Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models." Human Molecular Genetics 18.5 (2009): 824-834.
description	18.	Kohno, Y. "Homozygous female Becker muscular dystrophy." American journal of medical genetics. Part A 149.5 (2009): 1052-1055.
description	19.	RICHARD, I. "MUTATIONS IN THE PROTEOLYTIC-ENZYME CALPAIN-3 CAUSE LIMB-GIRDLE MUSCULAR-DYSTROPHY TYPE-2A." Cell 81.1 (1995): 27-40.
description	20.	Talkop, Ulvi-Astra A. "A descriptive epidemiological study of Duchenne muscular dystrophy in childhood in Estonia." European journal of paediatric neurology 7.5 (2003): 221-6.